Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species

Parasitology International

Volumn 60, Issue 4, 2011, Pages 357-363

  Valadares, Diogo G ^a   Duarte, Mariana C ^a   Oliveira, Jamil S ^a   Chávez Fumagalli, Miguel A ^a   Martins, Vivian T ^a   Costa, Lourena E ^a   Leite, João Paulo V ^b   Santoro, Marcelo M ^a   Régis, Wiliam C B ^c,d   Tavares, Carlos A P ^a   Coelho, Eduardo A F ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^c Minasfungi do Brasil LTDA ^*  (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Agaricus blazei Murill mushroom; Leishmania; Leishmanicidal activity; Treatment

Indexed keywords

AGARICUS BLAZEI EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; WATER;

AGARICUS BLAZEI; AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL VIABILITY; CONFOCAL MICROSCOPY; CYTOTOXICITY; ERYTHROCYTE; HEMOLYSIS; HUMAN; IC 50; IN VITRO STUDY; LEISHMANIA CHAGASI; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION;

AGARICUS; ANIMALS; CELLS, CULTURED; COMPLEX MIXTURES; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; LEISHMANIA; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MACROPHAGES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; WATER;

AGARICUS BLAZEI; BASIDIOMYCOTA; LEISHMANIA AMAZONENSIS; LEISHMANIA MAJOR; MURINAE;

EID: 82155197191     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2011.06.001     Document Type: Article

References (37)

1. Grimaldi G., Tesh R.B. Leishmaniasis of the New World: current concepts and implications for future research. Clin Microbiol Rev 1993, 6:230-250.
2. World Health Organization Leishmaniasis: the disease and its impact. WHO communicable diseases surveillance and response 2003, WHO, Geneva. http://www.who.int/emc/diseases/leish/leisdis1.html.
3. Thakur C.P., Sinha G.P., Pandey A.K., Kumar N., Kumar P., Hassan S.M., Narain S., Roy R.K. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Ann Trop Med Parasitol 1998, 92:561-569.
4. Sundar S., More D.K., Singh M.K., Singh V.P., Sharma S., Makharia A., Kumar P.C., Murray H.W. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000, 31:1104-1107.
5. Bhattacharya G., Herman J., Delfín D., Salem M.M., Barszcz T., Mollet M., Riccio G., Brun R., Werbovetz K.A. Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania. J Med Chem 2004, 47:1823-1832.
6. Tremblay M., Olivier M., Bernier R. Leishmania and the pathogenesis of HIV infection. Parasitol Today 1996, 12:257-261.
7. Grinde B., Hetland G., Johnson E. Effects on gene expression and viral load of a medicinal extract from Agaricus blazei Murill in patients with chronic hepatitis C infection. Int Immunopharmacol 2006, 6:1311-1314.
8. Talcott J.A., Clark J.A., Lee I.P. Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei Murill: a survey of Japanese consumers with cancer. BMC Complement Altern Med 2007, 29:7-32.
9. Firenzuoli F., Gori L., Lombardo G. The medicinal mushroom Agaricus blazei Murill: review of literature and pharmaco-toxicological problems. Evid Based Complement Altern Med 2008, 5:3-15.
10. Hsu C.H., Hwang K.C., Chiang Y.H., Chou P. The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B. J Altern Complement Med 2008, 14:299-301.
11. Sorimachi K., Akimoto K., Koge T. Inhibitory effect of Agaricus blazei Murill components on abnormal collagen fiber formation in human hepatocarcinoma cells. Biosci Biotechnol Biochem 2008, 72:621-623.
12. Gonzaga M.L., Bezerra D.P., Alves A.P., De Alencar N.M., Mesquita R.O., Lima M.W., Soares S.A., Pessoa C., De Moraes M.O., Costa-Lotufo L.V. In vivo growth-inhibition of sarcoma 180 by an alpha-(1->4)-glucan-beta-(1->6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill. Nat Med (Tokyo) 2009, 63:32-40.
13. Kim C.F., Jiang J.J., Leung K.N., Fung K.P., Lau C.B. Inhibitory effects of Agaricus blazei Murill extracts on human myeloid leukemia cells. J Ethnopharmacol 2009, 122:320-326.
14. Wasser S.P., Weis A.L. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives (review). Int J Med 1999, 1:31-62.
15. Hashimoto T., Nonaka Y., Minato K., Kawakami S., Mizuno M., Fukuda I., Kanazawa K., Ashida H. Suppressive effect of polysaccharides from the edible and medicinal mushrooms, Lentinus edodes and Agaricus blazei Murill, on the expression of cytochrome P450s in mice. Biosci Biotechnol Biochem 2002, 66:1610-1614.
16. Urben A.F. Caracterização morfológica e fisiológica de acessos de Agaricus blazei e A. sylvaticus. V Congresso latino americano de Micologia, Brasília 2005, 203-205.
17. Padilha M.M., Ávila A.A., Sousa P.J., Cardoso L.G., Perazzo F.F., Carvalho J.C. Anti-inflammatory activity of water and alkaline extracts from mushrooms (Agaricus blazei Murill). J Med Food 2009, 12:359-364.
18. Coelho E.A.F., Tavares C.A., Carvalho F.A., Chaves K.F., Teixeira K.N., Rodrigues R.C., Charest H., Matlashewski G., Gazzinelli R.T., Fernandes A.P. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun 2003, 71:3988-3994.
19. Coelho EAF. Avaliação dos níveis de proteção e da resposta imune induzida pela imunização com os antígenos A2 e LACK na infecção experimental com Leishmania (Leishmania) major e Leishmania (Leishmania) amazonensis. Doctoral Thesis. Department of Biochemistry and Immunology. Institute of Biological Sciences (ICB), UFMG. 2004.
20. Wagner H., Bland S., Zgainski E.M. Plant drug analysis 1984, Springer-Verlag, Berlim, 320 pp.
21. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956, 28:350-356.
22. Löfgren S.E., Miletti L.C., Steindel M., Bachère E., Barracco M.A. Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals. Exp Parasitol 2008, 118:197-202.
23. Tasdemir D., Kaiser M., Brun R., Yardley V., Schmidt T.J., Tosun F., Rüedi P. Anti-trypanosomal and leishmanicidal activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother 2006, 50:1352-1364.
24. Araújo C.A.C., Alegrio L.V., Leon L.L. Leishmanicidal activity of compounds extracted and characterized from Centrolobium sclerophyllum. Phytochemistry 1998, 49:751-754.
25. Akendengue B., Ngou-Milama E., Laurens A., Hocquemiller R. Recent advances in the fight against leishmaniasis with natural products. Parasite 1999, 6:3-8.
26. Delorenzi J.C., Attias M., Gattass C.R., Andrade M., Rezende C., Pinto A.C., Henriques A.T., Bou-Habib D.C., Saraiva B.E.M. Leishmanicidal activity of indole alkaloid from Peschiera australis. Antimicrob Agents Chemother 2001, 45:1349-1354.
27. Hatimi S., Boudouma M., Bichichi M., Chaib N., Idrissi N.G. In vitro evaluation of antileishmania activity of Artemisia herba alba Asso. Bull Soc Pathol Exot 2001, 94:29-31.
28. Ferreira I.C.P., Lonardoni M.V.C., Machado G.M.C., Leon L.L., Gobbi-Filho L., Pinto L.H.B., Oliveira A.J.B. Anti-leishmanial activity of alkaloidal extract from Aspidosperma ramiflorum. Mem Inst Oswaldo Cruz 2004, 99:1-3.
29. Buckner F.S., Wilson A.J. Colorimetric assay for screening compounds against Leishmania amastigotes grown in macrophages. Am J Trop Med Hyg 2005, 72:600-605.
30. Campos F.F., Rosa L.H., Cota B.B., Caligiorne R.B., Rabello A.L.T., Alves T.M.A., Rosa C.A., Zanil C.L. Leishmanicidal metabolites from Cochliobolus spp., an endophytic fungus isolated from Piptadenia adiantoides (Fabaceae). PLoS Negl Trop Dis 2008, 12:e348.
31. Kima P.E. The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist. Int J Parasitol 2007, 37:1087-1096.
32. Balaraman S., Tewary P., Singh V.K., Madhubala R. Leishmania donovani induces interferon regulatory factor in murine macrophages: a host defense response. Biochem Biophys Res Commun 2004, 317:639-647.
33. Mauël J., Ransijn A. Leishmania spp.: mechanisms of toxicity of nitrogen oxidation products. Exp Parasitol 1997, 87:98-111.
34. Mizuno T. Bioactive biomolecules of mushrooms: food function and medicinal effect of mushroom fungi. Food Rev Int 1995, 11:7-21.
35. Brown G.D., Gordon S. Fungal beta-glucans and mammalian immunity. Immunity 2003, 19:311-315.
36. Volman J.J., Mensink R.P., Van Griensven L.J., Plat J. Effects of alpha-glucans from Agaricus bisporus on ex vivo cytokine production by LPS and PHA-stimulated PBMCs; a placebo-controlled study in slightly hypercholesterolemic subjects. Eur J Clin Nutr 2010, 64:720-726.
37. Tempone A.G., Andrade H.F., Spencer P.J., Lourenço C.O., Rogero J.R., Nascimento N. Bothrops moojeni venom kills Leishmania spp. with hydrogen peroxide generated by its l-amino acid oxidase. Biochem Biophys Res Commun 2001, 280:620-624.